Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA approves Pfizer’s abuse-deterrent opioid painkiller

August 22, 2016 Sales and Marketing FDA, Pfizer, abuse deterrent, abuse-deterrent, approval, opioid, troxyca

Pfizer has announced that the US FDA has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules for the …
News

EU grants marketing authorisation for Teva’s asthma drug Cinqaero

August 19, 2016 Medical Communications, Sales and Marketing EU, Teva, approval, asthma, cinqaero, eosinophilic

The European Commission has granted marketing authorisation for Teva’s Cinqaero (reslizumab), as an odd-on therapy in adult patients with severe …
News

Bayer’s liver cancer drug not cost-effective, says NICE

August 19, 2016 Medical Communications, Sales and Marketing Bayer, CDF, NICE, Nexavar, lung cancer

NICE has deemed Bayer’s liver cancer drug Nexavar (sorafenib) as not cost-effective. The drug is currently available on the Cancer …
News

Former shareholders sue Valeant, alleging “vast fraud”

August 19, 2016 Medical Communications, Sales and Marketing Valeant, fraud, lawsuit, t rowe price

Valeant Pharmaceuticals has confirmed that it is being sued by one its former largest shareholders, T Rowe Price, who claim …
News

Chinese investors plan $1 billion US biotech site

August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

China’s state-backed developer Greenland Holdings is set to jointly invested over $1 billion in a San Francisco-based biotech industrial park …
News

J&J loses Remicade patent fight, pledges to continue fight against biosimilars

August 18, 2016 Research and Development, Sales and Marketing Johnson and Johnson, Remicade, biosimilar, biosimilars, infliximab, patent

Johnson and Johnson has announced that it has lost in a patent dispute between biosimilar makers Celltrion and Hospira, relating …
News

Pfizer’s Xalkori price drop secures NICE recommendation

August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Pfizer, Xalkori, crizotinib, lung cancer

The National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Xalkori (crizotinib) as a treatment for lung cancer, …
News

MSD joins Medivation race, says reports

August 18, 2016 Manufacturing and Production, Research and Development, Sales and Marketing MSD, Medivation, Merck, Pfizer, Sanofi, Xtandi, takeover

MSD, known as Merck in the US and Canada, is said to have declared its interest in buying US oncology …
News

NICE says Afinitor and Imbruvica “may be removed” from Cancer Drugs Fund

August 18, 2016 Research and Development, Sales and Marketing Afinitor, Cancer Drugs Fund, Janssen, NICE, Novartis, imbruvica

NICE has published draft guidance advising the removal of Novartis’s Afinitor (everolimus) and Janssen’s Imbruvica (ibrutinib) from the Cancer Drugs …
News

Amgen, Sanofi cholesterol medicines “not cost-effective”, need to drop price by two-thirds

August 17, 2016 Research and Development, Sales and Marketing Amgen, QALY, Regeneron, Repatha, Sanofi, cost effective, cost-effective, praluent

A new study published in JAMA has suggested that Amgen, Sanofi and Regeneron would have to reduce their prices for …
News

Ashfield launches Global Impact On Society Initiative

August 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield, part of UDG Healthcare plc (LON: UDG), a global leader in providing outsourced healthcare services to pharmaceutical, device and …
News
Press release

US court rules in favour of UCB in patent dispute, shares jump

August 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing UCB, lacosamide, patent, vimpat

UCB has received a major boost after a Delaware district court confirmed the validity of the company’s patents on one …
News

Top ten stories in the pharmaceutical industry this week

August 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
News

Acute coronary syndrome market to grow to over $12 billion by 2022

August 15, 2016 Research and Development, Sales and Marketing GlobalData, acute coronary syndrome

The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …
News

Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug

August 15, 2016 Sales and Marketing Endo, Endo International, abuse deterrent, opioid

Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …
News
The Gateway to Local Adoption Series

Latest content

Major funding opportunity opens for early cancer diagnostics

September 4, 2026

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026

CEPI backs African-led Bundibugyo Ebola vaccine development

September 3, 2026

Cytomos appoints life sciences executive to board

September 2, 2026

Cell therapy partnership aims to bring liver disease treatment closer to US patients

September 1, 2026